59 related articles for article (PubMed ID: 4599075)
1. [Letter: "Seroconversion rate" after influenza immunization].
Günther O; Seinsche D; von Mettenheim A
Dtsch Med Wochenschr; 1974 Mar; 99(12):597. PubMed ID: 4599075
[No Abstract] [Full Text] [Related]
2. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA
Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948
[TBL] [Abstract][Full Text] [Related]
3. [Possibilities and limits of vaccinations].
Schneeweiss B
Z Arztl Fortbild (Jena); 1971 May; 65(9-10):485-95. PubMed ID: 5114862
[No Abstract] [Full Text] [Related]
4. Routine vaccines across the life span, 2003.
Zimmerman RK; Middleton DB; Burns IT; Clover RD
J Fam Pract; 2003 Jan; 52(1 Suppl):S1-21. PubMed ID: 12556275
[TBL] [Abstract][Full Text] [Related]
5. Seroprotection rate, mean fold increase, seroconversion rate: which parameter adequately expresses seroresponse to influenza vaccination?
Beyer WE; Palache AM; Lüchters G; Nauta J; Osterhaus AD
Virus Res; 2004 Jul; 103(1-2):125-32. PubMed ID: 15163500
[TBL] [Abstract][Full Text] [Related]
6. Administration of inactivated trivalent influenza vaccine to parents of high-risk infants in the neonatal intensive care unit.
Shah SI; Caprio M; Hendricks-Munoz K
Pediatrics; 2007 Sep; 120(3):e617-21. PubMed ID: 17766502
[TBL] [Abstract][Full Text] [Related]
7. Is there a benefit from an early booster vaccination in the control of equine influenza?
Heldens JG; van Loon AA; van de Zande S
Vet J; 2007 Nov; 174(3):592-8. PubMed ID: 17560150
[TBL] [Abstract][Full Text] [Related]
8. E-rosette forming cells and humoral antibody titres in humans after vaccination with three different inactivated influenza virus vaccines A/USSR/92/77 (H1N1).
Schmidt S; Süss J; Oehring H; Schmidt J
Acta Virol; 1982 Dec; 26(6):466-73. PubMed ID: 6132540
[TBL] [Abstract][Full Text] [Related]
9. Effective nasal influenza vaccine delivery using chitosan.
Read RC; Naylor SC; Potter CW; Bond J; Jabbal-Gill I; Fisher A; Illum L; Jennings R
Vaccine; 2005 Aug; 23(35):4367-74. PubMed ID: 15916838
[TBL] [Abstract][Full Text] [Related]
10. Concurrent administration of rhesus rotavirus tetravalent (RRV-TV) vaccine with pentavalent diphtheria-pertussis-tetanus-Haemophilus influenzae beta-inactivated polio and hepatitis B vaccines.
Vesikari T; Joensuu J; Baer M; Käyhty H; Olander RM; Sormunen H; Miettinen A; Ward RL; Guillot T
Acta Paediatr; 1999 May; 88(5):513-20. PubMed ID: 10426173
[TBL] [Abstract][Full Text] [Related]
11. Local and systemic immune response in community-dwelling elderly after intranasal or intramuscular immunization with inactivated influenza vaccine.
Muszkat M; Yehuda AB; Schein MH; Friedlander Y; Naveh P; Greenbaum E; Schlesinger M; Levy R; Zakay-Rones Z; Friedman G
J Med Virol; 2000 May; 61(1):100-6. PubMed ID: 10745240
[TBL] [Abstract][Full Text] [Related]
12. [Seroconversion of antihemagglutinins into immunoglobulin fractions of different classes following vaccination with inactivated influenza vaccine].
Leĭbenzon AS
Lab Delo; 1984; (7):408-9. PubMed ID: 6207346
[No Abstract] [Full Text] [Related]
13. Cytotoxins in disease. 3. Antibodies against lymphocytes produced by vaccination.
Kreisler MJ; Hirata AA; Terasaki PI
Transplantation; 1970 Nov; 10(5):411-5. PubMed ID: 5490526
[No Abstract] [Full Text] [Related]
14. Transcutaneous immunization with inactivated influenza virus induces protective immune responses.
Skountzou I; Quan FS; Jacob J; Compans RW; Kang SM
Vaccine; 2006 Aug; 24(35-36):6110-9. PubMed ID: 16766095
[TBL] [Abstract][Full Text] [Related]
15. [Experiments with depot vaccines].
Henneberg G
Arzneimittelforschung; 1965 Sep; 15(9):1003-8. PubMed ID: 4955784
[No Abstract] [Full Text] [Related]
16. Head-to-head comparison of four nonadjuvanted inactivated cell culture-derived influenza vaccines: effect of composition, spatial organization and immunization route on the immunogenicity in a murine challenge model.
Hagenaars N; Mastrobattista E; Glansbeek H; Heldens J; van den Bosch H; Schijns V; Betbeder D; Vromans H; Jiskoot W
Vaccine; 2008 Dec; 26(51):6555-63. PubMed ID: 18848856
[TBL] [Abstract][Full Text] [Related]
17. Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2009 May; 58(19):521-4. PubMed ID: 19478718
[TBL] [Abstract][Full Text] [Related]
18. Vaccinology and selected virus diseases.
Dull HB
Adv Intern Med; 1971; 17():143-70. PubMed ID: 4950244
[No Abstract] [Full Text] [Related]
19. Immune response to influenza vaccine in adult liver transplant recipients.
Duchini A; Hendry RM; Nyberg LM; Viernes ME; Pockros PJ
Liver Transpl; 2001 Apr; 7(4):311-3. PubMed ID: 11303290
[TBL] [Abstract][Full Text] [Related]
20. Neuraminidase antibody response to inactivated influenza virus vaccine following intranasal and intramuscular vaccination.
Muhamed G; Greenbaum E; Zakay-Rones Z
Isr Med Assoc J; 2006 Mar; 8(3):155-8. PubMed ID: 16599048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
